ArticleMolecular therapy : the journal of the American Society of Gene Therapy2023

Safety and dose escalation of the targeted oncolytic adenovirus OBP-301 for refractory advanced liver cancer: Phase I clinical trial.

Jeong Heo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.